SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-025357
Filing Date
2023-05-31
Accepted
2023-05-31 16:29:28
Documents
13
Period of Report
2023-05-30
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K grna-20230530.htm   iXBRL 8-K 58912
  Complete submission text file 0000950170-23-025357.txt   213414

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grna-20230530.xsd EX-101.SCH 3461
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grna-20230530_pre.xml EX-101.PRE 12757
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grna-20230530_def.xml EX-101.DEF 13465
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grna-20230530_lab.xml EX-101.LAB 17532
7 EXTRACTED XBRL INSTANCE DOCUMENT grna-20230530_htm.xml XML 6478
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39894 | Film No.: 23981365
SIC: 2836 Biological Products, (No Diagnostic Substances)